This systematic review, titled "Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails," published in Sexual Medicine Reviews in 2019 (PMID: 30711478), evaluated the efficacy and safety of second-line oral combination therapies for erectile dysfunction (ED) in patients unresponsive to phosphodiesterase type 5
